The prothrombotic state in cancer

Benjamín Rubio-Jurado, Lluvia Sugey Sosa-Quintero, Sandra Guzmán-Silahua, Eduardo García-Luna, Carlos Riebeling-Navarro, Arnulfo Hernán Nava-Zavala*

*Autor correspondiente de este trabajo

Producción científica

1 Cita (Scopus)

Resumen

Neoplasms result from changes in the mechanisms of growth, differentiation, and cellular death. Cancers are of high clinical relevance due to their prevalence and associated morbidity and mortality. The clinical and biological diversity of cancer depends mainly on cellular origin and degree of differentiation. These changes result from alterations in molecular expression that generate a complex clinical, biochemical, and morphologic phenotype. Although cancer is associated with a hypercoagulable state, few cancers result in a thrombotic event. Many factors influence thrombotic incidence, such as advanced disease, central catheter placement, chemotherapy, neoplasia, and surgery. The pro-coagulant state is associated with anomalies in the vascular wall, blood flow, blood constituents (tissue factor, thrombin), coagulation state, and cell growth factors. Tumor cells perpetuate this phenomenon by releasing tissue factor, inflammatory cytokines, and growth factors. These changes favor cellular activation that gives rise to actions involving coagulation, inflammation, thrombosis, tumor growth, angiogenesis, and tumor metastases. These, in turn, are closely linked to treatment response, tumor aggressiveness, and host survival. Activation of the coagulation cascade is related to these phenomena through molecules that interact in these processes. As such, it is necessary to identify these mediators to facilitate treatment and improve outcomes.
Idioma originalEnglish
Título de la publicación alojadaAdvances in Clinical Chemistry
EditoresGregory S. Makowski, Gregory S. Makowski
EditorialAcademic Press Inc.
Páginas213-242
Número de páginas30
Volumen105
ISBN (versión impresa)9780128246276
DOI
EstadoPublished - ene 2021

Serie de la publicación

NombreAdvances in Clinical Chemistry
Volumen105
ISSN (versión impresa)0065-2423
ISSN (versión digital)2162-9471

Nota bibliográfica

Publisher Copyright:
© 2021 Elsevier Inc.

All Science Journal Classification (ASJC) codes

  • Química General
  • Bioquímica clínica

Huella

Profundice en los temas de investigación de 'The prothrombotic state in cancer'. En conjunto forman una huella única.

Citar esto